Search

Purpose: This study evaluated the intra‐ and inter‐fractional variation of tumors with fiducial markers (FMs), relative to the tumor‐FM distance, to establish how close an FM should be inserted for respiratory‐gated stereotactic body radiation therapy (RG‐SBRT). Methods: Forty‐five lung tumors treated with RG‐SBRT were enrolled. End‐expiratory computed tomography (CT) (CTplan) and four‐dimensional‐CT (4D‐CT) scans were obtained for planning. End‐expiratory CT (CTfr) scanning was performed before each fraction. The FMs were divided into two groups based on the median tumor‐FM distance in the CTplan (Dp). For the intra‐fractional variation, the correlations between the corresponding tumor and FM intra‐fractional motions, defined as the centroid coordinates of those in each 0–90% phase, with the 50% phase of 4D‐CT as the origin, were calculated in the left‐right, anterior‐posterior, and superior‐inferior directions. Furthermore, the maximum difference in the tumor‐FM distance in each phase of 4D‐CT scan, based on those in the 50% phase of 4D‐CT scan (Dmax), was obtained. Inter‐fractional variation was defined as the maximum distance between the tumors in CTplan and CTfr, when the CT scans were fused based on each FM or vertebra. Results: The median Dp was 26.1 mm. While FM intra‐fractional motions were significantly and strongly correlated with the tumor intra‐fractional motions in only anterior‐posterior and superior‐inferior directions for the Dp > 26 mm group, they were significantly and strongly correlated in all directions for the Dp ≤ 26 mm group. In all directions, Dmax values of the Dp ≤ 26 mm group were lower than those of the Dp > 26 mm group. The inter‐fractional variations based on the Dp ≤ 26 mm were smaller than those on the Dp > 26 mm and on the vertebra in all directions. Conclusions: Regarding intra‐ and inter‐fractional variation, FMs for Dp ≤ 26 mm can increase the accuracy for RG‐SBRT. [ABSTRACT FROM AUTHOR]

Unlike drug selection, radiation parameters (field, dose) are not based on driver gene mutations in patients with metastatic non-small cell lung cancer (NSCLC). This study aimed to compare radiosensitivity in NSCLC with and without EGFR driver gene mutations using clinical and in vitro data. The clinical study included 42 patients who underwent whole-brain radiotherapy for brain metastases from NSCLC; of these, 13 patients had EGFR mutation-positive tumors. The Kaplan–Meier method was used to calculate the cranial control rate without intracranial recurrence. In the in vitro study, colony formation and double-strand DNA breaks were examined in two EGFR mutation-negative and three EGFR mutation-positive NSCLC-derived cell lines. Colony formation was assessed 14 days after irradiation with 0 (control), 2, 4, or 8 Gy. DNA double-strand breaks were evaluated 0.5 and 24 h after irradiation. EGFR mutation-positive patients had a significantly better cranial control rates than EGFR mutation-negative patients (p = 0.021). EGFR mutation-positive cells formed significantly fewer colonies after irradiation with 2 or 4 Gy than EGFR mutation-negative cells (p = 0.002, respectively) and had significantly more DNA double-strand breaks at 24 h after irradiation (p < 0.001). Both clinical and in vitro data suggest that EGFR mutation-positive NSCLC is radiosensitive. [ABSTRACT FROM AUTHOR]

Background: The monocyte-to-lymphocyte ratio (MLR), a systemic inflammation biomarker, has been shown to predict patient outcomes in several types of cancer. This study aimed to determine the association between MLR and local control (LC) and cause-specific survival (CSS) rates in patients with non-small cell lung cancer (NSCLC) treated with stereotactic body radiation therapy (SBRT)., Materials and Methods: The median age of the 194 included participants (144 men, 50 women) was 80 (range, 50-96) years. The median follow-up period was 19 (range, 1-108) months. The LC and CSS rates were calculated using the Kaplan-Meier method. Univariate and multivariate Cox proportional hazard regression models were used to estimate the LC and CSS rates., Results: Local recurrence was observed in 25 patients during the follow-up. Univariate Cox proportional hazards regression analysis revealed that MLR, performance status, and tumor diameter were significant factors for LC. Multivariate analysis showed MLR and tumor diameter as significant factors (p = 0.041 and 0.031, respectively). The 1- and 2-year LC rates for the lower and higher MLR groups were 97.5% and 97.5%, and 89.7% and 81.2%, respectively. During the follow-up period, 14 patients died due to NSCLC. Although MLR tended to predict CSS in univariate analysis (p = 0.086), none of the parameters was significant in predicting CSS. However, MLR as a continuous variable was a significant factor for CSS in the univariate analysis (p = 0.004)., Conclusions: Our data suggest that MLR is correlated with LC and CSS rates in NSCLC patients treated with SBRT., Competing Interests: Conflicts of interest: Authors declare no conflict of interest., (© 2024 Greater Poland Cancer Centre.)